Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial
on behalf of the Dutch Autoimmune Hepatitis Group, Anna E.C. Stoelinga*, Maarten E. Tushuizen, Wilbert B. van den Hout, Mar D.M.Rodriguez Girondo, Elsemieke S. de Vries, Amar D. Levens, Dirk Jan A.R. Moes, Tom J.G. Gevers, Suzanne van der Meer, Hans T. Brouwer, Hendrik J.M. de Jonge, Ynte S. de Boer, Ulrich H.W. Beuers, Adriaan J. van der Meer, Aad P. van den Berg, Maureen M.J. Guichelaar, Joost P.H. Drenth, Bart van Hoek, Sjoerd F. BakkerJm Vrolijk, Patrick van der Veek, Nicole F. van Gerven
Research output: Contribution to journal › Article › Academic › peer-review
9Citations
(Scopus)
115Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial'. Together they form a unique fingerprint.